A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs
Recruiting now
Conditions studied: Drug Abuse, Intravenous, Substance Dependence, Needle Injury, Soft Tissue Injuries, Foreign Bodies
In brief
In addition to the well-known toxicological harms of intravenous drug (IVD) use, there can also be local tissue complications, including infections, venous sclerosis, tissue necrosis, and drug needle fragment retentions. Drug needle fragments in subcutaneous tissue may cause local symptoms (usually pain and infections), but they have also been identified as causing emboli to organs. The literature has described numerous case reports of people who inject drugs (PWIDs) and have retained needle fragments. The prevalence of the condition is not known, and the researchers therefore aim to perform the first cross-sectional study of PWIDs to estimate how common needle fragment retentions are and what their risk factors are in this population.
Key facts
- Study ID
- NCT05679284
- Run by
- Tampere University Hospital
- People needed
- 100
- Starts
- 2023-05-25
- Expected to finish
- 2028-11-15
- Last updated by the study team
- 2023-06-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- History of intravenous drug use
- Current treatment of the drug abuse problem at a local low-threshold drug abuse service unit or primary health care centre.
- Adherence to fill in the questionnaire
- Participation to X-ray imaging of injection sites
You may not qualify if…
- No history of intravenous drug use
- Does not adhere to fill in the questionnaire or refuses X-ray imaging
- Pregnancy
- Underage (18 years old)
Where it is running
- Hatanpää Health Center — Tampere, Finland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.